文献速递冠心病

老年NSTEACS患者有创与保守管理策略的个体患者数据荟萃分析

Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
PubMed 文献 · Eur Heart J · 2024-01-01

该研究基于6项随机对照试验的个体患者数据,比较70岁以上NSTEACS患者有创与保守管理策略。1年主要终点(全因死亡与心梗复合)在有创组为24.5%、保守组为28.9%,HR 0.87(95%CI 0.63-1.22;但有创组1年心梗风险(HR 0.62,95%CI 0.44-0.87;

要点

  • 老年NSTEACS患者有创策略未显著降低1年全因死亡与心梗复合终点。
  • 有创策略显著降低1年心梗风险(HR 0.62)和紧急血运重建风险(HR 0.41)。
  • 全因死亡风险两组间无显著差异。

核心结论

  • 常规有创策略未显著降低70岁以上NSTEACS患者1年全因死亡与心梗复合终点风险。
  • 有创策略显著降低1年心梗和紧急血运重建风险,全因死亡无显著差异。

研究设计与样本

  • 个体患者数据荟萃分析,检索MEDLINE、Web of Science和Scopus(2010年1月1日至2023年9月11日)。
  • 纳入6项随机对照试验,共1479例70岁以上NSTEACS患者。
  • 主要终点为1年全因死亡与心梗复合终点,采用随机效应和固定效应Cox模型进行一阶段IPD荟萃分析。

主要发现

  • 全因死亡风险两组间无显著差异。

临床怎么用

  • 对70岁以上NSTEACS患者,有创策略可显著降低1年心梗和紧急血运重建风险,但未显著改善全因死亡与心梗复合终点。
  • 临床决策需权衡有创策略的获益与风险,个体化选择血运重建策略。

局限性

  • 纳入研究数量较少(6项),总样本量1479例,证据力度有限。
  • 需要更大规模正在进行的临床试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Older patients with non-ST-elevation acute coronary syndrome (NSTEACS) are less likely to receive guideline-recommended care including coronary angiography and revascularization. Evidence-based recommendations regarding interventional management strategies in this patient cohort are scarce. This meta-analysis aimed to assess the impact of routine invasive vs. conservative management of NSTEACS by using individual patient data (IPD) from all available randomized controlled trials (RCTs) including older patients. METHODS: MEDLINE, Web of Science and Scopus were searched between 1 January 2010 and 11 September 2023. RCTs investigating routine invasive and conservative strategies in persons >70 years old with NSTEACS were included. Observational studies or trials involving populations outside the target range were excluded. The primary endpoint was a composite of all-cause mortality and myocardial infarction (MI) at 1 year. One-stage IPD meta-analyses were adopted by use of random-effects and fixed-effect Cox models. This meta-analysis is registered with PROSPERO (CRD42023379819). RESULTS: Six eligible studies were identified including 1479 participants. The primary endpoint occurred in 181 of 736 (24.5%) participants in the invasive management group compared with 215 of 743 (28.9%) participants in the conservative management group with a hazard ratio (HR) from random-effects model of 0.87 (95% CI 0.63-1.22; P = .43). The hazard for MI at 1 year was significantly lower in the invasive group compared with the conservative group (HR from random-effects model 0.62, 95% CI 0.44-0.87; P = .006). Similar results were seen for urgent revascularization (HR from random-effects model 0.41, 95% CI 0.18-0.95; P = .037). There was no significant difference in mortality. CONCLUSIONS: No evidence was found that routine invasive treatment for NSTEACS in older patients reduces the risk of a composite of all-cause mortality and MI within 1 year compared with conservative management. However, there is convincing evidence that invasive treatment significantly lowers the risk of repeat MI or urgent revascularisation. Further evidence is needed from ongoing larger clinical trials.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kotanidis, Mills, Bendz, et al. Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. Eur Heart J. 2024. PMID: 38596853. doi:10.1093/eurheartj/ehae151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。